((4-(1H-Pyrazol-1-yl)phenyl)(amino)methyl)phosphonic acid
|
|
2-(4-bromophenyl)-2-(butoxymethylamino)ethanehydroxamic acid |
|
2-(4-chlorophenyl)-5-fluoro-1,2-benzothiazol-3-one
|
|
2-(butoxymethylamino)-2-[4-(2,4,6-trifluorocyclohexa-2,4-dien-1-yl)phenyl]ethanehydroxamic acid |
|
2-[[(1-Amino-4-phenylbutyl)hydroxyphosphinyl]-methyl]-3-(4-hydroxyphenyl)propionic Acid |
|
2-[[(1-Amino-4-phenylbutyl)hydroxyphosphinyl]-methyl]-3-phenylpropionic Acid |
|
2-amino-1-hydroxyphosphonates
|
|
7-amino-4-phenyl-5,7,8,9-tetrahydro-6H-benzo[7]annulen-6-one
|
|
Alln
|
|
Alpha-aminoalkylphosphonates
|
|
and N-(1-(4-(1H-pyrazol-1-yl)phenyl)-2-(hydroxyamino)-2-oxoethyl)pivalamide |
|
Bestatin
|
|
Bestatin
|
|
Bufexamac
|
|
CHEMBL369831 |
|
CHEMBL426945 |
|
Chr-2863
|
|
Chr-6768
|
|
E-64
|
|
Hphep[ch2]phe) and 5 (hphep[ch2]tyr |
|
Menadione
|
|
MMV020750
|
|
Mmv665805
|
|
N-(2-(Hydroxyamino)–1-(4'-(hydroxymethyl)-[1,1'-biphenyl]–4-yl)–2-oxoethyl)pivalamide |
|
N-(2-(Hydroxyamino)-2-oxo-1-(3',4',5'-trifluoro-[1,1'-biphenyl]-4-yl)ethyl)adamantane1-carboxamide |
|
N-(2-(hydroxyamino)-2-oxo-1-(4-(3,4,5-trifluorocyclohexyl)phenyl)ethyl)-3-methylbutanamide |
|
Nitrobestatin
|
|
Pepstatin
|
|
Pro-arg-fluoromethyl ketone
|
|
silver nanoparticles
|
|
Substrate specificty suggested target
|
|
Suggested target
|
|
tert-butyl (1-(4-(1H-pyrazol-1-yl)phenyl)-2-(hydroxyamino)-2-oxoethyl)carbamate
|
|
tert-butyl N-[1-(4-bromophenyl)-2-(hydroxyamino)-2-oxo-ethyl]carbamate
|
|
Tosedostat
|
|